|Mr. Breno Toledo Pires de Oliveira||Chief Exec. Officer||N/A||N/A||N/A|
|Mr. Adalmario Ghovatto Satheler do Couto||Investor Relations Officer & CFO||N/A||N/A||N/A|
|Mr. Carlos Roberto Scorsi||Chief Operating officer||N/A||N/A||1962|
|Juliana Aguinaga DamiÃ£o Salem||Chief Legal & Compliance Officer||N/A||N/A||N/A|
|Mr. Nelson JosÃ© de Mello||Chief Corp. Relations Officer||N/A||N/A||1959|
|Mr. HÃ©lio Segouras||Head of Consumer Health||N/A||N/A||N/A|
|Mr. Claudio Bergamo dos Santos||Pres of Pharma & Director||N/A||N/A||1965|
|Mr. Martim Prado Mattos||Sec.||N/A||N/A||1980|
|Mr. Luiz Eduardo Violland||Chief Exec. Officer of the Pharmaceutical Division||N/A||N/A||N/A|
|Mr. Nicolas Fischer||Chief Exec. Officer of the Consumer Division||N/A||N/A||N/A|
Hypera S.A. operates as a pharmaceutical company in Brazil. It offers branded prescription products under the Mantecorp Farmasa, Episol, Predsim, Alivium, Lisador, Rinosoro, Celestamine, Maxsulid, Diprospan, Mioflex-A, and Addera D3 brands; dermo-cosmetics products under the Mantecorp Skincare brands; and consumer health products under the Apracur, Benegrip, Coristina d, Engov, Epocler, Estomazil, and other brands. The company also provides nutrition, sweeteners, and vitamin supplement products under the Tamarine, Vitasay 50+, BiotÃ´nico Fontoura, and Zero-Cal brands; and similar and generic medicines under the Neo QuÃmica, Torsilax, Neosoro, Doralgina, Flavonid, and Histamin brands. It sells its products through distributors and wholesalers. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypera S.A. was founded in 2001 and is headquartered in SÃ£o Paulo, Brazil.
O QualityScore de governança da ISS da Hypera S.A. a partir de 3 de dezembro de 2020 é 5. As principais pontuações para Auditoria são: 7; Conselho: 7; Direitos de Acionistas: 1; Compensação: 6.